Molecular analysis of pediatric brain tumors (Q35918862)

11 August 2017

1 reference

title

Molecular analysis of pediatric brain tumors (English)

1 reference

11 August 2017

1 reference

Jaclyn A Biegel

1

1 reference

PubMed ID

15485613

11 August 2017

Ian F Pollack

series ordinal

2

1 reference

11 August 2017

1 November 2004

1 reference

11 August 2017

Current Oncology Reports

1 reference

11 August 2017

6

1 reference

11 August 2017

6

1 reference

11 August 2017

445-452

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-004-0075-5

11 August 2017

0 references

cites work

The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression

1 reference

https://api.crossref.org/works/10.1007%2FS11912-004-0075-5

Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-004-0075-5

Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-004-0075-5

Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-004-0075-5

Multiple sequential molecular abnormalities in the evolution of human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-004-0075-5

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma.

21 January 2018

1 reference

12 December 2020

Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas.

1 reference

12 December 2020

Clinical and molecular stratification of disease risk in medulloblastoma

1 reference

12 December 2020

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

1 reference

12 December 2020

Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer

1 reference

12 December 2020

Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhood

1 reference

12 December 2020

Correlation of tumor O6 methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: a Southwest Oncology Group study.

1 reference

12 December 2020

Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations.

1 reference

12 December 2020

Ki-67 immunolabeling index is an accurate predictor of outcome in patients with intracranial ependymoma

1 reference

12 December 2020

CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.

1 reference

12 December 2020

A molecular genetic model of astrocytoma histopathology

1 reference

12 December 2020

Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2.

1 reference

12 December 2020

Deletions on the long arm of chromosome 17 in pilocytic astrocytoma.

1 reference

12 December 2020

p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression

1 reference

12 December 2020

Mitotic recombination of chromosome 17 in astrocytomas

1 reference

12 December 2020

Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance

1 reference

12 December 2020

Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors

1 reference

12 December 2020

Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors

1 reference

12 December 2020

Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities.

1 reference

12 December 2020

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

12 December 2020

Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers

1 reference

12 December 2020

Genetic alterations in pediatric high-grade astrocytomas.

1 reference

12 December 2020

High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.

1 reference

12 December 2020

Subsets of glioblastoma multiforme defined by molecular genetic analysis.

1 reference

12 December 2020

A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability

1 reference

12 December 2020

The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group

1 reference

12 December 2020

Proliferation index as a predictor of prognosis in malignant gliomas of childhood

1 reference

12 December 2020

The use of gene expression analysis to gain insights into signaling mechanisms of metastatic medulloblastoma.

1 reference

12 December 2020

Expression of two types of receptor for insulin-like growth factors in human malignant glioma.

1 reference

12 December 2020

Incidence of p14ARF gene deletion in high-grade adult and pediatric astrocytomas.

1 reference

12 December 2020

Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity

1 reference

12 December 2020

Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system.

1 reference

12 December 2020

The lack of a role for p53 in astrocytomas in pediatric patients.

1 reference

12 December 2020

Medulloblastoma growth inhibition by hedgehog pathway blockade

1 reference

12 December 2020

Progression as exemplified by human astrocytic tumors

1 reference

12 December 2020

Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas.

1 reference

12 December 2020

Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss.

1 reference

12 December 2020

Basic fibroblast growth factor expression as a predictor of prognosis in pediatric high-grade gliomas.

1 reference

12 December 2020

Basic fibroblast growth factor: a potential autocrine regulator of human glioma cell growth.

1 reference

12 December 2020

Analysis of HIC-1 methylation and transcription in human ependymomas

1 reference

12 December 2020

Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.

1 reference

12 December 2020

Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.

1 reference

12 December 2020

Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.

1 reference

12 December 2020

MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.

1 reference

12 December 2020

Classifying the medulloblastoma: insights from morphology and molecular genetics

1 reference

12 December 2020

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

1 reference

12 December 2020

Molecular cytogenetic studies of pediatric ependymomas

1 reference

12 December 2020

Alterations of the TP53 gene in human gliomas.

1 reference

12 December 2020

Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival.

1 reference

12 December 2020

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

1 reference

12 December 2020

Insulin and insulin-like growth factor I in brain tumors: binding and in vitro effects.

1 reference

12 December 2020

The influence of central review on outcome associations in childhood malignant gliomas: results from the CCG-945 experience

1 reference

12 December 2020

Cytogenetics and molecular genetics of childhood brain tumors

1 reference

12 December 2020

Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors

1 reference

12 December 2020

Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort.

1 reference

12 December 2020

Differential expression of platelet-derived growth factor receptors in human malignant glioma cell lines.

1 reference

12 December 2020

Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma

1 reference

12 December 2020

Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort

1 reference

12 December 2020

Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.

1 reference

12 December 2020

Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas

1 reference

12 December 2020

Treatment of infants with malignant gliomas: the Pediatric Oncology Group experience

1 reference

12 December 2020

Prediction of central nervous system embryonal tumour outcome based on gene expression

1 reference

12 December 2020

Molecular biology of medulloblastoma therapy

1 reference

12 December 2020

Association between chromosome 1p and 19q loss and outcome in pediatric malignant gliomas: results from the CCG-945 cohort

1 reference

12 December 2020

The molecular biology of ependymomas

1 reference

12 December 2020

High-grade astrocytomas in children: radiologically complete resection is associated with an excellent long-term prognosis.

1 reference

12 December 2020

Cytogenetic analysis of 39 pediatric central nervous system tumors

1 reference

12 December 2020

Chromosome abnormalities in pediatric brain tumors.

1 reference

12 December 2020

Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas.

1 reference

12 December 2020

Expression of p53 and prognosis in children with malignant gliomas.

1 reference

12 December 2020

Clonal expansion of p53 mutant cells is associated with brain tumour progression

1 reference

12 December 2020

Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development.

1 reference

12 December 2020

Prognostic factors in children with supratentorial (nonpineal) primitive neuroectodermal tumors. A neurosurgical perspective from the Children's Cancer Group.

1 reference

12 December 2020

The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood.

1 reference

12 December 2020

10.1007/S11912-004-0075-5

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15485613